![Kerri-Ann Millar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kerri-Ann Millar formerly worked at Flexion Therapeutics, Inc., as Controller from 2014 to 2017 and Cue Biopharma, Inc., as Chief Financial Officer from 2020 to 2025.
Ms. Millar received her undergraduate degree in 1992 from Boston University.
Anciens postes connus de Kerri-Ann Millar
| Sociétés | Poste | Fin |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur Financier/CFO | 13/06/2025 |
| FLEXION THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2017 |
Formation de Kerri-Ann Millar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
